| 000 | 01483 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517055155.0 | ||
| 264 | 0 | _c20160927 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.13362 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartins, Fátima O | |
| 245 | 0 | 0 |
_aMechanisms by which the thiazolidinedione troglitazone protects against sucrose-induced hepatic fat accumulation and hyperinsulinaemia. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJan 2016 |
||
| 300 |
_a267-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChromans _xtherapeutic use |
| 650 | 0 | 4 |
_aFatty Liver _xblood |
| 650 | 0 | 4 |
_aHyperinsulinism _xblood |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSucrose _xadministration & dosage |
| 650 | 0 | 4 |
_aThiazolidinediones _xtherapeutic use |
| 650 | 0 | 4 | _aTroglitazone |
| 700 | 1 | _aDelgado, Teresa C | |
| 700 | 1 | _aViegas, Joana | |
| 700 | 1 | _aGaspar, Joana M | |
| 700 | 1 | _aScott, Donald K | |
| 700 | 1 | _aO'Doherty, Robert M | |
| 700 | 1 | _aMacedo, M Paula | |
| 700 | 1 | _aJones, John G | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 173 _gno. 2 _gp. 267-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13362 _zAvailable from publisher's website |
| 999 |
_c25335097 _d25335097 |
||